HIV Care for Underrepresented Populations (AME)

This edition provides a comprehensive overview of drug resistance, a major barrier to effective antiretroviral therapy. You will be guided to solve this fundamental HIV puzzle step by step, from understanding how the virus evolves to escape the effect of a drug, to what consequences this eventually has for your clinical practice when managing patients with drug-resistant HIV strains.

Clinical management of people living with HIV seems straightforward due to highly effective and well-tolerated therapy. However, certain populations may require a more tailored approach. For instance, what should be taken into account when selecting an optimal regimen during pregnancy? Or how can engagement in care be increased for people who inject drugs?
You can find out this and more in this edition of the Online Meeting Highlights, dedicated to HIV care for underrepresented populations.
All modules can be followed independently and at your own pace. Complete the entire course to equip yourself with the knowledge to work towards making a significant impact on the survival and quality of life of your patients faced with these specific circumstances.
After following this eLearning activity, you will be able to:

• Understand key considerations in clinical management of HIV during pregnancy;
• Understand key considerations in clinical management of HIV in injection drug users;
• Reflect on epidemiology of HIV drug resistance, and understand its implications for choosing an optimal treatment regimen.

To obtain your certificate, you have complete all three modules, passed the relevant assessments and answered the evaluation survey.
Module 1 | HIV and Pregnancy
Module 2 | Managing HIV in Injection Drug Users
Module 3 | Update on HIV Drug Resistance
Duration: approximately 20 minutes per module
You can enhance your learning experience by:

• adding notes to the video modules;
• consulting the accompanying presentation slides;
• sharing your questions and observations with other learners in the discussion board; and
• referring to further literature and other materials provided to you by our experts.

The program is aimed at clinicians from various specialties who occasionally treat HIV patients, such as primary care physicians, family doctors, OBGYN, transgender healthcare clinicians, adolescent medicine professionals, and preventive medicine professionals, as well as public health workers and researchers engaged in HIV related disciplines at varying degrees.